Emerging Companies

The Hi-Tech department at EBN stands at the forefront of the Israeli technology landscape, representing a central focus within the firm. Our expertise extends to advising diverse clients, including early-stage startups, established companies, founders, entrepreneurs, senior management, and boards of directors, and navigating them through complex legal challenges. Our firm’s consistent recognition by prestigious domestic and international legal directories underscores our strong reputation in the market.

We provide a comprehensive suite of services spanning a broad spectrum of cutting-edge industries. From cybersecurity to automotive, AI, defense-tech, foodtech, fintech, cloud services to software development, and beyond, we provide end-to-end support to our clients.

Throughout the dynamic lifecycle of the Hi-Tech sector, we advise our clients through the maze of legal and commercial considerations. Our services encompass various activities from inception to capitalization, from growth through acquisitions to public listing or exit strategies. This includes facilitating commercial transactions, safeguarding intellectual property, negotiating licensing and technology agreements, and structuring joint ventures.

Our profound understanding of our clients’ businesses and objectives adds significant value to our services. We remain attuned to the evolving landscape of legal, technological, and business trends, ensuring our clients are well-positioned to seize emerging opportunities.

Our clients benefit from a dedicated team that seamlessly collaborates with other departments and practices within EBN that include tax, labor, privacy, IP, real estate and other.

Representation of Technology Companies

Arbe, Aryon, Anecdotes, Alpha Fortitude, Bluewhite, Bizzabio, Balena, CaseMate, Cymbio, Dream Security, DataGen, Digitalowl, Fortelix, Guesty, HyperGuest, Mobileye, Moodify, Moovex, Mediterranean Food Labs, Metis, Nilos, NYK, Oriient, PhaseV, Reco, SupPlant, 365Scores, Skyline Robotics, Urogen Pharma, Waterfall.

Representation in Fundraising 

• Urogen Pharma: $120M pipe transaction
• Guesty: $130M Series F Financing
• Fortellix: $85M Series C Financing
• DataGen: $50M Series C Financing
• Bluewhite: $39 Series C Financing
• Supplant: $38M Series C Financing
• RecoLabs: $30M Series A Financing
• Anecdotes: $25M Series B Financing
• Arbe Robotics: $23M private placement
• HyperGuest: $23M Series A Financing
• DigitalOwl: $20M Series A Financing
• Mediterranean Food Lab: $17M Series A Financing
• PhaseV: $15M Series Seed Financing

Representation in Exit Transactions

• Permira in the acquisition of control in BioCatch at a company valuation of USD 1.305 billion
• Vertex Ventures in the sale of its holdings in Adaptive Shield to CrowdStrike at a company valuation of $300 million.
• Emerge Ventures, Insight Partners and Square Peg in the sale of their holdings in Deci AI to Nvidia
• 365 scores in its aquation by Entain for $150M
• Moovex.ai in its sale to iCabbi
• TEOCCO in the sale of its service assurance division to Amdocs
• Arbe Robotics (NASDAQ) in its de-SPAC transaction with Industrial Tech Acquisitions
• Hellman & Friedman in the purchase of Checkmarx for USD 1.15 billion.
• Amiti Ventures, Amdocs Ventures and Singtel Innov8 in the sale of their holdings in Flow Security to CrowdStrike
• Walmart on various acquisitions, including of Zeekit and Aspectiva.
• Byond Trust (a Francisco Partners portfolio company) on its acquisition of Entitle

Representation in Company Acquisitions

• Guesty: Acquisitions of Kigo Inc., HiRUM, and MyVR Inc.
• Bizzabo: Acquisitions of Klik, Whalebone, x.ai, and Teevid assets.